Prognostic significance of CD117 expression and TP53 missense mutations in triple-negative breast cancer

Triple-negative breast cancer (TNBC) is extremely aggressive and associated with poor prognosis. There are no known predictive or prognostic markers for TNBC. Inhibition of tumor protein P53 (TP53) has been demonstrated to increase the levels of cluster of differentiation 117 (CD117) in human colore...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Yanli, Huang, Wentao, Zhang, Huizhen, Liu, Guang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5876428/
https://www.ncbi.nlm.nih.gov/pubmed/29616097
http://dx.doi.org/10.3892/ol.2018.8104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5876428/
https://www.ncbi.nlm.nih.gov/pubmed/29616097
http://dx.doi.org/10.3892/ol.2018.8104

Ejemplares similares